New Cicon Pharmaceutical

New Cicon Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and chemical intermediates. The company focuses on several therapeutic areas, including anti-infectives, anti-inflammatories, and cardiovascular treatments. New Cicon operates high-standard manufacturing facilities that comply with international GMP regulations, serving both domestic and global markets. In addition to its own product portfolio, the company provides contract manufacturing (CMO) and development services to other pharmaceutical entities. Its core strengths lie in chemical synthesis and the production of high-quality bulk drugs.